Trial Profile
The Comparative Safety and Effectiveness of Sitagliptin in Patients with Type 2 Diabetes and Heart Failure
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Apr 2014
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary) ; Antihyperglycaemics; Metformin; Sulfonylureas
- Indications Heart failure; Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 07 Apr 2014 New trial record